After Hours Report

Updated: 23-Feb-26 17:28 ET
Keysight powers higher while Hims & Hers Health slides lower following earnings

While stocks weathered some volatility late last week to chart a higher finish, the market faced a sharp retreat today, with the S&P 500 (-1.0%), Nasdaq Composite (-1.1%), and DJIA (-1.7%) finishing firmly lower across the board. The S&P 500 closed below its 50-day moving average (6,895.83) and moved back into negative territory for the year. 

The Russell 2000 (-1.6%) and S&P Mid Cap 400 (-1.8%) closed with even wider losses, underscoring a broad "risk off" tone in today's trade. 

Morning headlines revolved around tariff uncertainty after President Trump raised the Section 122 global tariff rate to 15% from 10% and warned this morning that he would impose additional tariffs on countries that attempt to revisit recent trade agreements with the U.S. The threat was made just hours after it was reported that the EU is pausing the approval of the trade deal, pending further review. Late this afternoon, Politico reported that it is unlikely that Congress will have the votes to extend the Section 122 tariffs past 150 days, adding to the uncertainty around the situation.

Unsurprisingly, many stocks in the consumer discretionary sector (-2.2%) struggled, especially those that rely on overseas manufacturing and large import volumes, such as Williams-Sonoma (WSM 201.89, -12.97, -6.04%), lululemon athletica (LULU 178.11, -9.19, -4.91%), and NIKE (NKE 63.08, -2.32, -3.55%). 

Elsewhere in the sector, casino and travel-related names such as Expedia Group (EXPE 188.51, -14.97, -7.36%) and MGM Resorts (MGM 34.26, -2.54, -6.89%) charted even wider losses. 

Tesla (TSLA 399.83, -11.99, -2.91%) and Amazon (AMZN 205.27, -4.84, -2.30%) finished lower amid a tough day for mega-cap tech, which saw the Vanguard Mega Cap Growth ETF finish 1.3% lower. 

The market is no stranger to weakness across mega-cap and tech names this year, particularly in the software space. 

Microsoft (MSFT 384.60, -12.63, -3.18%) was a Magnificent Seven laggard, providing weak leadership for an already beleaguered software space. The iShares GS Software ETF finished 4.7% lower as renewed fears of AI disruption saw software names such as Datadog (DDOG 102.62, -13.04, -11.28%) and CrowdStrike (CRWD 350.33, -38.27, -9.85%) plot some of the widest retreats in both the information technology sector (-1.1%) and the broader S&P 500. 

IBM (IBM 223.38, -33.78, -13.13%) faced the widest retreat, which was attributed to news that Claude can automate COBOL modernization. 

Software weakness added to pressure across asset manager names, which were already under pressure following reports last week that Blue Owl Capital (OWL 10.45, -0.36, -3.35%) is restricting redemptions. 

For PE firms with meaningful general partner stakes in portfolio companies tied to traditional enterprise software, uncertainty around future earnings and exit prospects weighed on sentiment, sending stocks such as KKR (KKR 92.19, -8.99, -8.89%) and Ares Management (ARES 114.57, -8.59, -6.97%) firmly lower. 

Meanwhile, fears that AI disruption could slow high-income spending sent ripples across stocks in the payment space lower, such as American Express (AXP 321.24, -24.94, -7.20%) and Capital One (COF 190.00, -18.42, -8.84%).

The industrials sector (-1.4%) also saw a continuation of weakness attributed to AI-disruption fears, including couriers such as C.H. Robinson (CHRW 177.20, -12.86, -6.77%) and data services such as Equifax (EFX 188.43, -9.03, -4.57%).

Defensive names garnered some rotational interest today amid the pronounced weakness in the broader market, sending the consumer staples (+1.5%), healthcare (+1.2%), and utilities (+0.7%) sectors to the top of today's leaderboard. Walmart (WMT 125.81, +2.82, +2.29%) rebounded from a modest post-earnings slide, while Eli Lilly (LLY 1058.56, +49.04, +4.86%) traded sharply higher after its competitor Novo Nordisk A/S (NVO 39.63, -7.79, -16.43%) reported weaker results for its newest weight-loss drug. 

Outside of the stock market, Bitcoin retreated under the $65,000 mark, adding to a sense of volatility across risk assets today. 

All told, it was a tough session for stocks, with pronounced software and mega-cap weakness combining with weak participation in the broader market. Today's renewed selling pressure across pockets of the market that have seen volatility amid fears of AI disruption could signal that last week's higher finish was more of a technical rebound and not a change in sentiment. Without material gains from semiconductors or other AI buildout stocks to offset the weakness in disrupted pockets of the market, the major averages will continue to struggle to break out from their current levels.

U.S. Treasuries began the week on a firmly higher note, sending the 5-yr yield toward its low from 2025 (3.530%) amid an uptick in trade tensions and ongoing weakness in asset managers. The 2-year note yield settled down four basis points to 3.44%, the 5-year note yield settled down seven basis points to 3.58%, and the 10-year note yield settled down six basis points to 4.03%. 

  • S&P Mid Cap 400: +7.2% YTD
  • Russell 2000: +5.6% YTD
  • DJIA: +1.5% YTD
  • S&P 500: -0.1% YTD
  • Nasdaq Composite: -2.6% YTD

Reviewing today's data:

  • Factory orders declined 0.7% month-over-month in December (Briefing.com consensus: 0.9%) following a 2.7% increase in November. Excluding transportation, factory orders increased 0.4% after increasing 0.1% in November. Shipments of manufactured goods rose 0.5% after sliding 0.2% in November.
    • The key takeaway from the report is that the weakness was concentrated in the transportation industry; otherwise, it was a decent month of order activity for durable goods.

Overseas:

  • Europe: DAX -1.1%, FTSE flat, CAC -0.2%
  • Asia: Nikkei market closed, Hang Seng +2.5%, Shanghai market closed

Commodities:

  • Crude Oil -0.19 @ 66.30
  • Nat Gas -0.05 @ 2.99
  • Gold +146.30 @ 5226.20
  • Silver +4.24 @ 86.52
  • Copper +0.06 @ 5.78

After-Hours Spotlight:

  • Allison Transmission (ALSN) misses by $0.37, beats on revs; guides FY26 revs above consensus...ALSN -4.1%
  • Bed Bath & Beyond (BBBY) beats by $0.28, beats on revs; issues FY26 guidance...BBBY +3.6%
  • BioMarin Pharmaceutical (BMRN) reports Q4 (Dec) results, beats on revs; guides FY26 revs below consensus...BMRN -2.6%
  • Clearway Energy, Inc. (CWEN) Reports Full Year 2025 Financial Results; reaffirms FY26 financial guidance range...CWEN -5.9%
  • Diamondback Energy (FANG) misses by $0.26, beats on revs; Issues 2026 production guidance...FANG -3.1%
  • Hims & Hers Health (HIMS) beats by $0.04, reports revs in-line; guides Q1 revs below consensus; guides FY26 revs in-line...HIMS -2.0%
  • Keysight (KEYS) beats by $0.17, beats on revs; guides Q2 EPS, revs above consensus...KEYS +15.1%
  • Kratos Defense and Security (KTOS) beats by $0.02, beats on revs; guides Q1 revs below consensus; guides FY26 revs in-line...KTOS -2.2%
  • MediaAlpha (MAX) beats by $0.26, misses on revs; guides Q1 revs above consensus; increases share repurchase authorization to $100 mln...MAX +11.3%
  • Myriad Genetics (MYGN) beats by $0.05, beats on revs; guides Q1 revs below consensus; reaffirms FY26 revs guidance...MYGN +19.8%
  • Paymentus (PAY) beats by $0.04, beats on revs; guides Q1 revs in-line; guides FY26 revs below consensus...PAY -5.3%
  • Primoris Services (PRIM) beats by $0.10, beats on revs; guides FY26 EPS in-line...PRIM -4.6%
  • Ultra Clean Holdings (UCTT) reports EPS in-line, beats on revs; guides Q1 EPS in-line, revs in-line...UCTT -12.0%

Fair Value for Tuesday, February 24:

  • S&P 500: 6,850
  • Nasdaq 100: 24,762
  • DJIA: 48,842
Today's News Summary:

For a full rundown of today's market and after hours developments, see Live In Play

  • Earnings/Guidance (Full Earnings Calendar):
    • A2Z Cust2Mate Solutions Corp (AZ) sees Q4 revs above consensus
    • Amicus Therapeutics (FOLD) beats by $0.03, beats on revs
    • Axsome Therapeutics (AXSM) reports Q4 (Dec) results, revs in-line
    • Centene (CNC) management team plans to reaffirm guidance this week
    • Dominion Energy (D) beats by $0.01, beats on revs; guides FY26 EPS in-line, extends through 2030 its long-term annual operating earnings-per-share-growth guidance of 5-7%
    • Domino's Pizza (DPZ) misses by $0.03, beats on revs; raises dividend
    • Dream Finders Homes (DFH) misses by $0.06; beats on revs
    • Easterly Government Properties (DEA) reports FFO in-line, revs in-line; guides FY26 FFO in-line
    • Emera (EMA) beats by $0.13
    • Equinox Gold (EQX) has filed its audited financial statements and related management’s discussion and analysis for the three months and year ended December 31, 2025
    • Freshpet (FRPT) beats by $0.26, reports revs in-line; guides FY26 revs in-line
    • ImmunityBio (IBRX) beats on top and bottom lines
    • GeneDx (WGS) beats by $0.04, reports revs in-line; reaffirms FY26 revs guidance
    • Sasol (SSL) reports H1 results
    • Stepan Company (SCL) misses by $0.42 (two estimates), misses on revs
  • General News
    • President Trump raises global tariff to 15% from 10% for 150 days to replace the IEEPA tariffs that the Supreme Court invalidated; White House details several product and country exemptions; Commerce Department is expected to start various 301 investigations to impose permanent tariffs on specific countries
    • US Customs and Border Protection will stop collecting IEEPA tariffs as of Tuesday at 12:01 A.M ET
    • USTR Jamieson Greer says the U.S. will honor trade deals despite the Supreme Court ruling, according to CBS News
    • White House continuing the suspension of duty-free De Minimis treatment for all countries
    • European Commission statement on the recent judgment of the Supreme Court of the United States; requests full clarity on the steps the United States intends to take following the recent Supreme Court ruling
    • An armed man was killed by law enforcement after he entered a secure perimeter of Mar-a-Lago, according to the NY Times
    • The EU will propose freezing ratification of the trade deal with the U.S. until it receives details from the Trump administration on trade policy, according to Bloomberg
    • The EU will not accept an increase in tariffs, according to Reuters
    • The U.S. will hold nuclear talks with Iran Thursday. President Trump's advisors are urging him not to bomb Iran, but Senator Lindsey Graham wants President Trump to ignore his advisors, according to Axios
    • President Trump is considering a targeted strike on Iran, followed by a larger attack, according to NY Times
    • Mexico security forces killed drug kingpin Nemesio "Mencho" Oseguera. The response was violent, WSJ
    • DHS implements emergency measures to conserve resources and manpower impacting travelers and FEMA responses to non-disaster areas
    • Airlines cancel thousands of flights due to winter storms, according to CNBC
    • Joint Chiefs Chairman General Dan Caine advising President Trump that a strike against Iran will carry significant risks; Jared Kushner and Steve Witkoff want to give diplomacy a chance, according to Axios
    • Abivax (ABVX) presents first evidence of anti-fibrotic activity for Obefazimod alongside new clinical efficacy and safety analyses in inflammatory bowel disease at ECCO 2026
    • ADC Therapeutics (ADCT) has entered into an amendment to its royalty purchase agreement with entities managed by HealthCare Royalty
    • Affirm (AFRM): NY Governor Hochul unveils rules to license and rein in Buy Now, Pay Later lenders in New York
    • Amazon (AMZN) selects Louisiana for $12 billion data center campuses in major U.S. expansion
    • Amazon (AMZN) refutes FT.com story about AI being to blame for brief service interruption
    • American Electric (AEP): Southwestern Electric Power Co announces a new data center investment from Amazon (AMZN) that company leaders describe as the most significant economic development win Northwest Louisiana has seen in a generation
    • Anthropic: Defense Secretary Pete Hegseth close to cutting ties with Anthropic, according to Axios
    • Apple (AAPL) could make push into visual artificial intelligence, according to Bloomberg
    • Arbutus Biopharma (ABUS): Delaware Court issues summary judgment rulings in Arbutus, Genevant patent case against Moderna (MRNA)
    • Armata Pharmaceuticals (ARMP) receives FDA qualified infectious disease product designation for AP-SA02
    • ASP Isotopes (ASPI) announces Quantum Leap Energy and Necsa advance strategic collaboration aimed at production of HALEU nuclear fuel
    • AST SpaceMobile (ASTS) has entered into an agreement with the United States Space Development Agency for the Europa Track 2 Commercial Solutions program
    • BAE Systems (BAESY) has successfully demonstrated scaled electromagnetic attack capabilities during multiple test events using a modular version of its high-performance hardware, which is designed to neutralize adversary air defenses and disrupt their use of the electromagnetic spectrum for battlespace coordination
    • Benitec Biopharma (BNTC) announces the acceptance of a late-breaking abstract for the BB-301 Phase 1b/2a Clinical Treatment Study ongoing in Oculopharyngeal Muscular Dystrophy Patients with moderate dysphagia
    • Blackstone Life Sciences (BX) announces a research and development funding agreement to advance the clinical development of bleximenib, an investigational oral menin inhibitor, for acute myeloid leukemia
    • Bridger Aerospace Group (BAER) awarded $18.6 mln contract from Department of Interior
    • Bristol-Myers (BMY) announces positive top-line results from registrational phase 2 study of Luspatercept in adults with Alpha (a)-Thalassemia
    • Caledonia Mining (CMCL) provides a further update on the interim funding facility forming part of the funding strategy announced in January 2026
    • Carlyle Secured Lending (CGBD) was informed Justin Plouffe is resigning from the Board and his positions as the President and Chief Executive Officer of the Company
    • Carnival Corporation (CCL) and Carinval Plc enter unification agreement to unify under a single company
    • Citigroup (C) nears agreements to divest additional Banamex stake to Blackstone-Linked (BX) investors and Televisa Co-Chiefs, according to Bloomberg
    • Comstock (LODE) has been placed on a very select list of companies authorized as universal waste recyclers that can treat photovoltaic modules
    • CRISPR Therapeutics (CRSP): FDA launches framework for accelerating development of individualized therapies for ultra-rare diseases
    • Delta Air Lines (DAL) expects to suspend operations at its New York-LGA, New York-JFK and Boston Logan hubs into Tues, Feb. 24 due to extreme winter weather conditions
    • Entravision (EVC) terminated the employment of Jeffery Liberman, President and Chief Operating Officer, effective immediately
    • ExlService (EXLS) announces a critical transformation initiative with Sonos (SONO), the world’s leading sound experience company, and Amazon (AMZN) Web Services
    • Five9 (FIVN) entered into cooperation agreement with Anson Funds Management LP, including the nomination of Sagar Gupta for election to the Board
    • Fortune Brands (FBIN): Ed Garden built a stake in Fortune Brands and wants a new CEO, according to WSJ
    • Franco-Nevada (FNV) commits A$220 mln to Bullabulling gold project
    • GlaxoSmithKline (GSK) and Bora Pharmaceuticals (BORAY) sign$250 mln strategic agreement to renew a five-year manufacturing partnership
    • Hamilton Lane (HLNE) commences repurchases under its existing stock repurchase program
    • InMode (INMD) announces conclusion of independent transaction committee review
    • Int'l Paper (IP): Packaging stocks showing weakness pre-market; attributed to drop in containerboard prices
    • Johnson & Johnson (JNJ) reports TREMFYA (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
    • Johnson & Johnson (JNJ) announces that the European Commission has approved an extension of the RYBREVANT marketing authorisation to include additional subcutaneous dosing regimens
    • JP Morgan (JPM) CEO Jamie Dimon will try to convince investors of his $2 billion/week spending plan, according to FT
    • JP Morgan (JPM) acknowledged de-banking President Trump following January 6th, according to NY Times
    • Scotts Miracle-Gro (SMG) discloses that its Hawthorne business met held-for-sale criteria and will be reported as a discontinued operation
    • Merck (MRK) confirms it evolves Human Health operating structure to support portfolio execution
    • Microsoft (MSFT): OpenAI resets spending expectations; providing a lower number and more defined timeline for its planned spending, according to CNBC
    • Moller Maersk (AMKBY) and others take temporary control of Panama Canal ports, according to FT
    • MoonLake (MLTX) reports topline results from its Phase 2 clinical trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
    • Netflix (NFLX): President Trump says NFLX should fire Board member Susan Rice, "immediately, or pay the consequences"
    • Novartis (NVS) highlights remibrutinib data in CSU and peanut allergy at AAAAI
    • Novo Nordisk's (NVO) CagriSema shows 23% weight loss but misses non-inferiority vs tirzepatide
    • Nvidia (NVDA) will introduce chips for laptops this year, according to WSJ
    • NVIDIA (NVDA) is collaborating with cybersecurity providers Akamai (AKAM), Forescout, Palo Alto Networks (PANW) and Xage Security, as well as Siemens (SIEGY), to bring accelerated computing and AI to OT cybersecurity, advancing real-time threat detection and response across critical infrastructure
    • Organon (OGN) entered into an agreement to exclusively license global rights to MIUDELLA, Sebela Pharmaceuticals’ hormone-free copper intrauterine device (IUD) contraceptive
    • PENN Entertainment (PENN) announces the appointment of three new independent directors, Heather Ace, Jeffrey Fox and Fabio Schiavolin, to its Board of Directors, effective immediately
    • ProCap Financial (BRR) announces it repurchased 148,241 shares of its common stock in the open market on Friday, February 20, 2026
    • Sandoz (SDZNY) secures EU approval for Ranluspec ranibizumab biosimilar
    • Savara (SVRA) announces that the FDA filed for review the BLA for MOLBREEVI as a therapy to treat patients with autoimmune PAP
    • Sigma Lithium (SGML) provides production guidance
    • South Plains Financial (SPFI) authorizes $10 mln stock repurchase program
    • Steel Dynamics (STLD) increases quarterly cash dividend 6% to $0.53/share from $0.50/share
    • Stepan Company (SCL) announces $100 million pre-tax cost out and efficiency plan to support global operations optimization
    • US Foods (USFD) launches Menu IQ: AI-Powered tool giving restaurant operators real-time visibility into menu profitability
    • Vale S.A. (VALE) informs on estimates update
    • Vanda Pharma (VNDA) receives FDA approval for BYSANTI for bipolar I disorder and schizophrenia
    • Verisk Analytics (VRSK) enters $1.5 bln accelerated share repurchase
    • WISeKey (WKEY) to relocate Geneva HQ and launch Quantum Center in 2026
    • Xcel Energy (XEL) required to take prompt action to protect Texas against potential wildfires after temporary injunction filed by Texas AG
    • Yext (YEXT) and AdCellerant partner to help organizations manage and optimize brand visibility
  • Upgrades:
    • Acadia Pharmaceuticals (ACAD) upgraded to Outperform from Neutral at Mizuho, tgt $35
    • Alphabet (GOOGL) upgraded to Overweight from Equal Weight at Wells Fargo, tgt $387
    • Banco Santander (SAN) upgraded to Outperform from Sector Perform at RBC Capital
    • BlackRock (BLK) upgraded to Buy from Neutral at UBS, tgt $1,280
    • CBRE Group (CBRE) upgraded to Buy from Neutral at UBS, tgt $185
    • Henry Schein (HSIC) upgraded to Outperform from Neutral at Robert W. Baird, tgt $100
    • ICON plc (ICLR) upgraded to Buy from Hold at Jefferies, tgt $135
    • J.M. Smucker (SJM) upgraded to Buy from Neutral at BofA Securities, tgt $130
    • Macerich (MAC) upgraded to Overweight from Sector Weight at KeyBanc, tgt $25
    • Nvidia (NVDA) upgraded to Buy from Hold at Aletheia, tgt $250
    • Norsk Hydro (NHYDY) upgraded to Buy from Neutral at Citigroup
  • Downgrades:
    • Deere (DE) downgraded to Underperform from Hold at Jefferies, tgt $550
    • DocuSign (DOCU) downgraded to Hold from Buy at Jefferies, tgt $45
    • Freshworks (FRSH) downgraded to Hold from Buy at Jefferies, tgt $8
    • General Mills (GIS) downgraded to Neutral from Buy at BofA Securities, tgt $48
    • Harmony Biosciences (HRMY) downgraded to Hold from Buy at Deutsche Bank
    • Imperial Oil (IMO) downgraded to Underperform from Sector Perform at RBC Capital
    • Infosys (INFY) downgraded to Hold from Buy at Jefferies, tgt $14.31
    • monday.com (MNDY) downgraded to Hold from Buy at Jefferies, tgt $80
    • Rio Tinto (RIO) downgraded to Neutral from Buy at Goldman
    • Vertical Aerospace (EVTL) downgraded to Underperform at Raymond James
    • VF Corp. (VFC) downgraded to Underweight from Neutral at JPMorgan, tgt $18
    • Workday (WDAY) downgraded to Hold from Buy at Jefferies, tgt $150
  • Others:
    • Amprius Technologies (AMPX) initiated with a Buy at Craig-Hallum, tgt $17
    • Bob's Discount Furniture (BOBS) initiated with a Buy at DA Davidson, tgt $26
    • Ethos Technologies (LIFE) initiated with a Buy at BofA Securities, tgt $15
    • Ethos Technologies (LIFE) initiated with an Outperform at William Blair
    • Ethos Technologies (LIFE) initiated with a Buy at Citigroup, tgt $15
    • Ethos Technologies (LIFE) initiated with an Overweight at JPMorgan, tgt $13
    • Ethos Technologies (LIFE) initiated with an Overweight at Barclays, tgt $20
    • Ethos Technologies (LIFE) initiated with an Outperform at Citizens, tgt $21
    • Ethos Technologies (LIFE) initiated with an Outperform at Robert W. Baird, tgt $18
    • Ethos Technologies (LIFE) initiated with a Buy at Goldman, tgt $33
    • H2O America (HTO) initiated with an Overweight at Barclays, tgt $61
    • MiMedx Group (MDXG) initiated with an Outperform at Citizens, tgt $10
    • PicPay (PICS) initiated with an Outperform at RBC Capital, tgt $20
    • PicPay (PICS) initiated with a Buy at Citigroup, tgt $28
    • Yuanbao (YB) initiated with a Neutral at Citigroup, tgt $21.80
    • York Space Systems (YSS) initiated with an Overweight at Wells Fargo, tgt $35
    • York Space Systems (YSS) initiated with an Outperform at Raymond James, tgt $55
    • York Space Systems (YSS) initiated with a Hold at Truist, tgt $30
    • York Space Systems (YSS) initiated with a Buy at Canaccord, tgt $36
    • York Space Systems (YSS) initiated with an Outperform at Robert W. Baird, tgt $40
    • York Space Systems (YSS) initiated with a Buy at Needham; tgt $42
    • York Space Systems (YSS) initiated with an Overweight at JPMorgan, tgt $49
    • York Space Systems (YSS) initiated with a Neutral at Goldman, tgt $29
    • York Space Systems (YSS) initiated with a Buy at Citigroup; tgt $37
  • Econ Data (Tuesday):
    • 9:00 ET: December FHFA Housing Price Index (Briefing.com consensus 0.4%; prior 0.6%) and December S&P Case-Shiller Home Price Index (Briefing.com consensus 1.4%; prior 1.4%)
    • 10:00 ET: February Consumer Confidence (Briefing.com consensus 86.0; prior 84.5) and December Wholesale Inventories (Briefing.com consensus 0.2%; prior 0.2%)
  • Earnings:
    • Monday (Feb 23)
      • Pre-Market: AXSM D DPZ DEA EMA FRPT WGS SCL
      • After-Hours: ACVA ADUS ALSN AESI BBBY BCC BMRN BWXT CNNE CWEN FANG EVER FWRD HLX HIMS IIPR INVX JBTM KEYS KTOS MAX MYGN OKE OVV PAY PRIM KWR RHP SKWD TNC UFPI UCTT VVX VNOM VIR ZD
      Tuesday (Feb 24)
      • Pre-Market: AHCO AIN AS AMT APLS AWI ARVN AVNS BNS BRSL CECO CEG CIFR CLVT DOCN ELAN NVRI ESTA EXPD FERG FIS FWRG HRMY HSIC HD TILE KDP KNSA DRS LTH NOVT NRG OPCH PLNT PTLO RGEN SHLS SHC WLK XHR XMTR
      • After-Hours: ATEC AMC AXON ATRO SAM BBIO CWH CDNA CAVA CCC IMOS CLNE CORT CSGP CYTK DAWN ECG EVH EXLS EXPI EOG FSLR FLYW GMED GDDY HPQ HURN IPAR JAZZ LNWO LTC LCID MQ MTDR MATX MMSI MOS MELI NMFC PARR PRCT RRC O REZI RVLV SLDE SPXC SUI SUPN TALO SKT TEM TMDX TREX UFPT PCVX VRRM WDAY ZETA
    • Wednesday (Feb 25)
      • Pre-Market: ACHC ALKS APG AROC ASPN AVA BMO BLMN CTRI CRCL YOU DIN DOLE DRVN FSS HAYW HUT HOV HNI IMCR IONS LFST LINE LIVN LOW MDLN MGPI NMRK ODD OC PLAB PNW RXRX SWX STWD SHOO TBLA TJX TPH UTHR XPEL
      • After-Hours: ACAD ADMA APA ADTN A ALKT RCUS ARRY BBSI BJRI AI WHD CWT CBZ CHE CPK CHYM CHRD CHDN DBRG DORM ECPG ENVX EPR WTRG EE FSK FTAI GDRX GRBK HEI IBTA IMAX NGVT IONQ JOBY KNTK KGS LMAT MGNI VAC MIAX MIRM MEG MYRG NSA NRDS NOG NTNX NVDA ORA OUT PSKY PEB PR PSTG RVMD ROOT RXST CRM SRPT SDGR SDRL SEZL SBGI SKYT SM SMA SNOW SARO SNPS TDOC TTD TKO TCOM USPH UHS URBN VECO VCYT VICI VSEC ZM
    • Thursday (Feb 26)
      • Pre-Market: ACMR GOLF AMBP ARHS ACIW BIDU BSY ONC BCRX CARS CELH LNG CQP CM COLL QBTS DCI DCO ECVT EME ENOV FA FTRE FTDR FCN FOUR ROCK GCT GIL GTN HTZ HRL IBP IART NTLA INSW SJM KBR KRP KOP DNUT KYMR LNTH LGND LOAR MNKD MIDD TIGO VYX NXST NOMD NVCR NVAX PZZA PAYO PENN PRGO PLTK PRMB PRVA PEG Q RYTM RY SRE SHAK TGLS TFX BLD TD TRS PRKS VTRS VCEL VIPS VISN VST VITL WD WRBY WBD WWW
      • After-Hours: ALHC AMBA AHR AAOI ACA ARLO AGO AUGO ADSK AVPT AES XYZ BCO CAI CERT CON CRWV CTRA CPNG CRNX CUBE DELL XRAY DRH DV DUOL ESTC EVTC FIGS FIGR FLUT FOXF GLOB GRND HGV ICFI INOD INTU MASI MTZ MNST MP NTRA NHI NATL NTAP LASR SMR OS OPK PCRX PAR PBA PGNY RLJ RKT RKLB SBAC SOLV SOUN STRA RUN SG SNDX TLN WULF BWIN REAL TPC WPM XPOF ZS
    • Friday (Feb 27)
      • Pre-Market: AMR ANIP BTSG CLMT DK FRO NIQ GOGO NWN SHO
      • After-Hours: GSAT
Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.